Oxley Bridge Acquisition Limited Overview
Oxley Bridge Acquisition Limited is a $253 million Nasdaq-listed blank-check company. It was formed in August 2024 and closed its IPO in June 2025. Its sponsor is controlled by Jonathan Hou Pu Lin, co-founder and CIO of L2 Capital. Its stated mandate is to merge with a global consumer or technology business that has disruptive growth potential and can benefit from expanding in Asia. Mainland China, Hong Kong and Macau are explicitly excluded. It initially targets enterprise values of about $500 million to $1.0 billion. The management bench combines public-market investors, private-equity and venture investors, and operating "enterprise builders" across Canada, Hong Kong, Singapore and the Philippines. As of 30 June 2026 it held $262.8 million in trust, or $10.39 per public share, in Treasury money-market funds. It had no definitive agreement and about 12 months left to close a deal. Its investment case therefore rests on sponsor deal-sourcing, with a floor near trust value.
Company's own description (10-K FY2025). The company describes itself as a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. It may pursue a target in any industry. It is searching globally for a target in the consumer and technology sectors with disruptive growth potential through technology that can benefit from operations in Asia, excluding China (defined to include Hong Kong and Macau). It has generated no operating revenue and does not expect to until it completes a business combination.
Business model. The economics are those of a standard US-listed SPAC:
Revenue model mix. Product 0%, service 0%, subscription 0%, licensing 0%. The only income is non-operating interest and dividends on trust and cash balances.
Value chain position and customers. None in the conventional sense. Functionally, OBA is a capital-markets intermediary. It offers a private company an alternative route to a US listing and access to the trust cash, subject to redemptions. Its "customers" are prospective targets and its investors.
Independent characterization. OBA is a mid-sized, Cantor-led SPAC with a cross-border Asia thesis. The China exclusion is a deliberate regulatory de-risking choice, given US scrutiny of China-linked listings. It narrows the target universe to Southeast Asia, India, Japan, Korea, Australia and global companies with Asian expansion plans. The stated enterprise-value band of $500M–$1.0B is about 2–4× the trust. A completed deal would therefore likely need PIPE, forward-purchase or non-redemption financing if redemptions are material.
Strategy
Stated strategy themes (10-K FY2025). Management argues that the downturn in private markets has weeded out flawed business models and left strong-moat private companies available. It seeks proven business models that can be tailored to Asia for accelerated growth. It frames its mission as being "thought partners" to companies entering public markets. Three secular themes are cited:
Acquisition criteria (10-K FY2025).
-
Initial target enterprise value of about $500M–$1.0B.
-
Large, under-penetrated markets.
-
Companies that would benefit from a US listing.
-
Unique positioning and customer stickiness.
-
Category leadership with sustainable competitive advantage.
-
A public-market-ready management team.
-
Proven monetization, attractive unit economics, high operating leverage, and recurring revenue with strong lifetime value relative to acquisition cost.
-
Hard exclusion of China, Hong Kong and Macau-based targets.
Initiatives in the last 24 months. The IPO (June 2025) and the appointment of a President (July 2025) are the only disclosed initiatives. There are no transformation programs, cost programs or ESG commitments.
Guidance and targets. None. The company states it does not currently intend to seek an extension. If it does, it does not expect to go beyond 36 months from the IPO closing.
Contingent strategic levers disclosed.
-
Extension vote, which would trigger redemptions.
-
Sponsor sale to a replacement sponsor, which would change management.
-
Forward-purchase or backstop agreements.
-
PIPE equity or debt at closing.
-
Sponsor forfeiture or restructuring of founder shares and warrants to facilitate a deal.
Products & Services
OBA has no products, brands, platforms or services. Its only "offerings" are its listed securities and the capital structure it can provide to a target:
"Offering" to targets (10-K FY2025). Trust cash (before redemptions), flexible cash, stock or debt consideration, faster and more certain listing than a traditional IPO, and management's operating and capital-markets support.
Product Portfolio
| Instrument | Ticker | Key terms | Launch | Pricing |
|---|---|---|---|---|
Units | OBAWU | 1 Class A share + ½ warrant | 25 Jun 2025 | $10.00 at IPO |
Class A ordinary shares | OBA | Redeemable for pro rata trust value at deal, extension vote or liquidation | 15 Aug 2025 | Trades near trust value |
Public warrants | OBAWW | 12,650,000 outstanding; $11.50 strike; exercisable 30 days post-deal; 5-year life; redeemable at $0.01 if shares ≥$18.00 for 20 of 30 trading days | 15 Aug 2025 | ~$0.22 (aggregator quote) |
Private placement warrants | Not listed | 6,400,000; same terms with transfer restrictions; Cantor's capped at 5 years under FINRA 5110(g)(8) | 26 Jun 2025 | $1.00 |
Class B founder shares | Not listed | 6,325,000; convert 1:1 (anti-dilution to 20%); sole vote on directors pre-deal | Aug 2024 | ~$0.004 |
Financial Narrative
Income statement (annual)
Notes:
-
The FY2025 trust income figure is derived as the 31 Dec 2025 trust balance ($258,227,025) less the deposit ($253,000,000). This assumes no withdrawals; none are disclosed.
-
FY2025 operating expenses, EBITDA and EPS by class were not captured in the sections of the 10-K reviewed and are not publicly disclosed here.
-
Gross, operating, EBITDA and net margins are undefined with zero revenue. Revenue CAGR is not meaningful.
Interim income statement (six months)
Source: 10-Q Q2 FY2026.
Quarterly results
Q1 FY2026 net income was $2,116,110 (10-Q Q2 FY2026, statement of changes in deficit). Nine-month FY2025 net income was $2,443,288 (Stock Titan summary of the Q3 FY2025 10-Q).
Trust account progression
The Jun 2025 and Mar 2026 balances are derived: the Jun 2025 figure is the deposit plus Q2 FY2025 trust income, and the Mar 2026 figure is the Dec 2025 balance plus Q1 FY2026 remeasurement. Mar 2026 per-share value is derived. All other figures are disclosed.
Balance sheet
FY2024 total debt is the derived IPO promissory note balance: the $242,318 drawn by IPO less $175,892 of 2025 draws reported in the H1 FY2025 cash-flow statement. The H1 FY2026 column is a balance-sheet date (30 Jun 2026), not a fiscal year. The large shareholders' deficit is an accounting artifact. Public shares are carried as temporary equity at redemption value, and the accretion is charged to equity. It does not indicate insolvency of the trust.
Cash flow
The full-year FY2025 cash-flow statement was not captured in the sections reviewed. Free cash flow equals operating cash flow, because capex is zero.
Ratios
Ratios are derived. The annualized trust yield is H1 FY2026 trust income × 2 ÷ the opening trust balance. ROE, ROA, ROIC, net debt/EBITDA, interest coverage, asset turnover and the cash conversion cycle are not meaningful: equity is negative by construction, there is no debt, no EBITDA and no operating cycle.
Commentary
The financial story has three parts.
First, trust accretion drives everything. Treasury money-market yields of about 3.5% annualized add roughly $0.09 per share per quarter. Redemption value rose from $10.00 to $10.39 in twelve months. Net income is simply trust income less a small expense base. It will fall once the company signs a deal and transaction costs are expensed, or if rates fall.
Second, the expense base is rising but small. H1 FY2026 G&A of $237k was more than double the pre-IPO H1 FY2025 figure, and the $12,500 monthly sponsor fee now runs at its full rate. Annualized, outside-trust burn is about $0.5M against $0.73M of cash. On current burn, the company can reach roughly mid-2027 without sponsor loans. Any serious diligence, legal or banking spend on a target would bring forward the need for working capital loans; up to $1.5M can be converted into warrants.
Third, management has flagged substantial doubt about the company's ability to continue as a going concern. This is standard SPAC language tied to the June 2027 mandatory liquidation date. It does not signal impairment of trust assets.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment (USD) and Segment Assets & Liabilities (USD)
| Metric | FY2024 | FY2025 |
|---|---|---|
Single segment revenue (USD) | 0 | 0 |
Single segment net income (USD, derived) | -48,833 | 4,782,187 |
Single segment total assets (USD) | — | 259,327,478 |
Share of total revenue (%) | 0 | 0 |
Group Entities
| Entity | Role | Control |
|---|---|---|
Oxley Bridge Acquisition Limited | Listed SPAC (Cayman) | Board appointed solely by Class B holders before the deal |
Oxley Bridge Holdings LLC | Sponsor; holds all 6,325,000 Class B shares and 4.2M private warrants | Managing member is Oxley Bridge Management LLC |
Oxley Bridge Management LLC | Managing member of Sponsor | Sole managing member is Jonathan Lin |
Sponsor affiliate (unnamed) | Receives $12,500/month for office and admin support | Described as "an affiliate of the Sponsor" (10-Q) and "the managing member of our Sponsor" (10-K). Wording differs between filings. |
Income Statement (USD)
| Metric | FY2024 | FY2025 |
|---|---|---|
Revenue (USD) | 0 | 0 |
Gross profit (USD) | 0 | 0 |
Increase in trust balance from income (USD, derived) | 0 | 5,227,025 |
Net income (USD, derived) | -48,833 | 4,782,187 |
Dividends per share (USD) | 0 | 0 |
Dividends & Capital Returns (USD) and Per-Share Data
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
General & administrative expenses (USD) | 104,248 | 237,391 |
Administrative expenses – related party (USD) | 2,083 | 75,000 |
Loss from operations (USD) | -106,331 | -312,391 |
Income on trust investments (USD) | 115,349 | 4,576,349 |
Dividend income (USD) | 0 | 14,234 |
Net income (USD) | 9,018 | 4,278,192 |
EPS Class A, basic & diluted (USD) | 0.00 | 0.14 |
EPS Class B, basic & diluted (USD) | 0.00 | 0.14 |
Dividends & Capital Returns (USD)
| Metric | Q2 FY2025 | Q2 FY2026 |
|---|---|---|
G&A (USD) | 91,286 | 112,614 |
Admin – related party (USD) | 2,083 | 37,500 |
Trust income (USD) | 115,349 | 2,305,775 |
Dividend income (USD) | 0 | 6,421 |
Net income (USD) | 21,980 | 2,162,082 |
Key Financials (USD)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
Trust balance (USD) | 253,115,349 | 255,759,767 | 258,227,025 | 260,497,599 | 262,803,374 |
Value per public share (USD) | 10.00 | 10.11 | 10.21 | 10.30 | 10.39 |
Balance Sheet (USD)
| Metric | FY2024 | FY2025 | H1 FY2026 |
|---|---|---|---|
Cash & equivalents outside trust (USD) | 0 | 978,307 | 729,941 |
Prepaid expenses – total (USD) | — | 122,146 | 123,396 |
Total current assets (USD) | — | 1,060,807 | 853,337 |
Investments held in trust (USD) | 0 | 258,227,025 | 262,803,374 |
Total assets (USD) | — | 259,327,478 | 263,656,711 |
Accounts payable (USD) | 34,056 | 24,012 | 75,053 |
Total current liabilities (USD) | — | 111,507 | 162,548 |
Deferred underwriting fee (USD) | 0 | 12,045,000 | 12,045,000 |
Total liabilities (USD) | — | 12,156,507 | 12,207,548 |
Total debt (USD) | 66,426 | 0 | 0 |
Class A subject to redemption (USD) | 0 | 258,227,025 | 262,803,374 |
Shareholders' deficit (USD) | -23,833 | -11,056,054 | -11,354,211 |
Working capital (USD) | — | 949,300 | 690,789 |
Goodwill & intangibles (USD) | 0 | 0 | 0 |
Cash Flow (USD)
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
Net cash used in operating activities (USD) | -92,826 | -248,366 |
Cash deposited into trust (USD) | -253,000,000 | 0 |
Proceeds from units (USD) | 253,000,000 | 0 |
Proceeds from private warrants (USD) | 6,400,000 | 0 |
Underwriting fees paid (USD) | -4,400,000 | 0 |
Offering costs paid (USD) | -293,908 | 0 |
Promissory note repayment (USD) | -242,318 | 0 |
Net change in cash (USD) | 1,370,958 | -248,366 |
Capex (USD) | 0 | 0 |
Dividends paid / buybacks (USD) | 0 | 0 |
Financial Ratios (x) and Returns & Leverage Ratios (%)
| Ratio | FY2025 | H1 FY2026 |
|---|---|---|
Current ratio (x) | 9.51 | 5.25 |
Debt/equity (x) | 0 | 0 |
Annualized trust yield (%) | — | 3.54 |
Cash burn outside trust, 6 months (USD) | — | 248,366 |
Geographic Revenue
| Region | FY2024 | FY2025 |
|---|---|---|
Americas revenue (USD) | 0 | 0 |
EMEA revenue (USD) | 0 | 0 |
APAC revenue (USD) | 0 | 0 |
Securities on Issue
| Security | Observation | Source |
|---|---|---|
OBAWU | $10.03 (4 Aug 2025); $10.08 (10 Oct 2025) | MarketBeat |
OBA | $10.10 (13 Feb, likely 2026) | YCharts |
OBA | $10.29–$10.32 (recent) | Tiger Brokers; Fidelity |
OBA 52-week range | $9.93–$10.25 | OptionsAnalysisSuite |
OBAWU 52-week range | $10.00–$11.25 (conflicts with other ranges; may reflect thin unit trading) | Tiger Brokers |
OBAWW | ~$0.22 | ROIC.ai |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
P/E (trailing, aggregator) | 34–47x quoted | Not meaningful: earnings are trust interest |
Price / trust value per share | ~0.99x ($10.30 ÷ $10.39) | Analyst-derived; the relevant SPAC metric |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None; no sell-side coverage identified |
Dividends | None; none expected pre-deal |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | No debt. The $12.045M deferred underwriting fee is a contingent liability payable only on completion. |
Potential dilution | 19,050,000 warrants (12.65M public + 6.4M private) at $11.50; up to $1.5M of loans convertible into warrants at $1.00; Class B anti-dilution conversion |
Analyst Conclusions
Management guidance. None. Management will either announce a definitive agreement, seek an extension (it says it does not currently intend to, and not beyond 36 months), or liquidate after 26 June 2027.
Consensus. None available.
Bull case
-
Downside protection with a free option. Shares trade near $10.30 against a trust of $10.39 that accretes about 3.5% a year. Holders can redeem at any deal or extension vote, so near-term downside is close to nil while a deal announcement could re-rate the warrants.
-
Credible deal team with institutional backing. Lin's MDP, Citigroup and L2 Capital background and Cantor's sponsorship increase the probability of a sourced, financeable transaction in the $500M–$1B EV band.
-
Differentiated ex-China Asia thesis. By excluding China it avoids the regulatory discount that has hurt many Asia-linked de-SPACs, while targeting faster-growing Southeast Asian and Indian digital markets.
Bear case
-
Clock risk. Fifteen months after IPO there is no LOI. Historically, many SPACs without a target at this stage end up extending with heavy redemptions or liquidating, in which case warrants expire worthless.
-
Misaligned incentives and dilution. About $63M of founder-share value at trust price ($25k cost), plus 19M warrants and a $12M deferred fee, pushes the sponsor toward any deal and imposes a material cost on a target.
-
Redemption and financing risk. Even with a deal, high redemptions could leave little trust cash. The deal would then depend on PIPE or forward-purchase capital in an environment still sceptical of de-SPAC performance.
Catalysts and monitorables (next 12 months)
-
Any 8-K announcing an LOI or definitive agreement, and the identity, sector, geography and valuation of the target.
-
PIPE, forward-purchase or non-redemption agreements.
-
Sponsor working capital loans, an early signal of rising diligence spend.
-
Q3 FY2026 10-Q (expected ~November 2026) and FY2026 10-K (~March 2027).
-
A proxy for an extension vote ahead of June 2027, and the level of redemptions.
-
Any sponsor sale or management change.
-
Changes in Treasury yields, which drive trust accretion.
-
Changes in 13G/13F holder composition (arbitrage funds exiting would signal low deal expectations).
Analyst verdict
Oxley Bridge Acquisition Limited is best understood as a fully cash-backed, time-limited call option on the deal-making ability of Jonathan Lin's sponsor group. It is not an operating business that can be valued on earnings or growth. The trust holds $262.8 million, or $10.39 per public share at 30 June 2026, in Treasury money-market funds. It grows by roughly nine cents per quarter, and the balance sheet carries no debt. For a public shareholder, the economic floor is effectively the redemption value. The thesis therefore turns entirely on whether management can sign and close an attractive transaction before 26 June 2027.
The evidence to date is neutral to modestly negative. The IPO was well received, with the over-allotment fully exercised. The team combines private-equity, investment-banking and Asian operating credentials, and the China exclusion is a sensible regulatory hedge. However, the company had no definitive agreement a full year after listing, and none has been disclosed through the latest filing. Management has formally flagged going-concern doubt. Cash outside the trust is modest relative to the diligence and legal spend a real deal would require.
The structure also deserves scrutiny. A 20% promote acquired for $25,000, 19.05 million warrants and a $12.045 million deferred fee create incentives to complete a transaction regardless of quality. The value public holders retain will depend on deal terms, redemption levels and any sponsor concessions.
For yield-oriented, trust-arbitrage holders, OBA's Class A shares are a low-risk instrument that trades close to trust value. For investors seeking upside, the warrants offer leveraged exposure to a deal announcement but carry a meaningful risk of expiring worthless. The key monitorables are a definitive-agreement 8-K, accompanying PIPE or forward-purchase commitments, and any extension proxy. Until a target is named, a fundamental rating beyond "trust-value hold" is not supportable.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Age (at IPO) | Background | Education | Citizenship / residence |
|---|---|---|---|---|---|---|
Jonathan Hou Pu Lin | Chairman & CEO; controls Sponsor | Since inception (Aug 2024) | 41 | Co-founder, Partner & CIO of L2 Capital (founded 2020); 18+ years of investing; Madison Dearborn Partners 2008–2010 (TMT); Citigroup M&A, New York; advisory board of Oxley Bridge Capital (Singapore) | B.Com, University of British Columbia | Canada per 10-K; Schedule 13G lists United States. The filings conflict. Spends time in Canada, Singapore and Hong Kong. |
Gary Kar Yin Chan | Chief Financial Officer; CODM | Since IPO period | 57 | 25+ years in financial management and public/private equity; founder member & Managing Partner, Atlas Investment Management (mid-market buyouts); MD & Head of Research, VMS Investment Group; formerly an SFC Responsible Officer in Hong Kong | BS Finance, Indiana University; MS Financial Markets, Illinois Institute of Technology | Hong Kong |
Jingjing ("Jessi") Yan | President | Appointed 28 Jul 2025 | — | Career history is set out in the 8-K. | — | Australian citizen; resides in Hong Kong |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Independence | Management-team label | Residence |
|---|---|---|---|---|
Jonathan Lin | Chairman | Non-independent | Public market specialist | Canada / Singapore / HK |
Norma Chu | Director | Independent | Enterprise builder | Hong Kong |
Enrique Gonzalez | Director | Independent | Enterprise builder | Philippines |
Wee Leong Gan | Director | Independent | Private market specialist | Singapore |
Jack Cho | Director | Independent | Private market specialist | Hong Kong (US citizen) |
Major Shareholders
| Holder | Class | Shares | % of class | % of total | Date / filing |
|---|---|---|---|---|---|
Oxley Bridge Holdings LLC / Oxley Bridge Management LLC / Jonathan Lin | Class B | 6,325,000 | 100% | 20.0% (10-K shows 20.23%) | 13G event date 31 Dec 2025; 10-K as of 30 Mar 2026 |
Magnetar Financial LLC / Magnetar Capital Partners / Supernova Management / David J. Snyderman | Class A | 1,250,000 | 4.94% | ~3.95% | 13G/A filed 12 Nov 2025 |
Competitive Landscape
Key Competitors
| Competitor category | Nature of competition | Relative position of OBA |
|---|---|---|
Other SPACs (especially 2024–2026 vintage, Asia- and tech-focused) | Bid for the same pool of listing-ready targets; rising SPAC formation increases competition and target bargaining power | Mid-sized trust ($263M); Cantor-led; China exclusion narrows the pool |
Private equity funds | Offer certain cash exits without redemption risk | SPAC offers liquidity and public currency but less certainty |
Venture and growth investors / crossover funds | Offer private capital without listing obligations | SPAC offers a listing path |
Traditional IPO underwriters | Alternative listing route | SPAC is faster but carries dilution and redemption risk |
Strategic acquirers | Trade sales | SPAC lets owners keep exposure to upside |
Direct listings / regional exchanges (e.g. SGX, ASX, HKEX) | Alternative listing venues for Asian companies | US listing offers deeper capital; HKEX unlikely for targets OBA would consider given its exclusion |
Recent Developments
No litigation, regulatory actions, guidance revisions or layoffs have occurred.



